Q32 Bio Inc. (QTTB)

Q32 Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	352	35	72	208	511	912
Market Cap Growth	-7.37%	-51.37%	-65.18%	-59.29%	-43.94%	8.72%
Enterprise Value	234	54	-73	74	308	648
PE Ratio	-	-0.31	-14.47	-2.17	-3.97	-8.77
PS Ratio	993.83	30.47	22.58	6.12	189.13	547.13
PB Ratio	7.21	-0.19	0.41	1.23	2.61	3.53
P/FCF Ratio	-0.65	-0.37	-0.63	-1.85	-5.21	-8.05
P/OCF Ratio	-0.65	-0.37	-0.64	-1.90	-5.42	-9.98
EV/Sales Ratio	662.27	46.94	-22.79	2.18	113.91	388.87
EV/EBITDA Ratio	0.77	-0.49	43.24	-0.86	-2.57	-6.64
EV/EBIT Ratio	0.75	-0.48	17.05	-0.77	-2.39	-6.23
EV/FCF Ratio	0.74	-0.57	0.64	-0.66	-3.14	-5.72
Debt / Equity Ratio	0.38	-0.27	0.17	0.14	0.08	-
Debt / EBITDA Ratio	-0.23	-0.46	-17.43	-0.28	-0.13	-
Debt / FCF Ratio	-0.22	-0.52	-0.26	-0.21	-0.16	-
Quick Ratio	4.13	2.22	7.75	9.16	9.65	21.31
Current Ratio	4.19	2.04	8.02	11.14	9.69	21.54
Asset Turnover	0.00	0.01	0.01	0.14	0.01	0.01
Return on Equity (ROE)	-452.60%	-255.90%	-2.20%	-48.30%	-65.40%	-42.60%
Return on Assets (ROA)	-65.30%	-81.50%	-1.80%	-40.90%	-49.50%	-34.60%
Return on Capital (ROIC)	-131.78%	76.48%	-64.25%	-49.56%	-61.61%	-42.53%
Earnings Yield	-23.62%	-320.69%	-6.91%	-46.03%	-25.18%	-11.40%
FCF Yield	-23.93%	-272.27%	-158.71%	-53.91%	-19.19%	-12.42%
Buyback Yield / Dilution	-577.31%	-0.76%	-3.83%	-20.41%	-9.01%	-47.51%
Total Shareholder Return	-577.31%	-0.76%	-3.83%	-20.41%	-9.01%	-47.51%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).